Inventor · disambiguated record
Siew Ho Schleyer
Also filed as: SCHLEYER SIEW · SCHLEYER SIEW HO
9 granted patents·5 pending applications·26 citations·filing 2007–2024
84Inventor score
Top patents by PatentIndex Score
14 records- 0192US9789203B2cKIT antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Oct 17, 2017·11 cites·31 claims
- 0289US10786578B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2015·Granted Sep 29, 2020·4 cites·12 claims
- 0388US12171839B2Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2022·Granted Dec 24, 2024·1 cites·11 claims
- 0487US10117953B2Antibody drug conjugatesNOVARTIS AG·Filed 2016·Granted Nov 6, 2018·2 cites·15 claims
- 0587US9498543B2Antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Nov 22, 2016·5 cites·15 claims
- 0679US2025064964A1Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0775US2020129632A1Antibody drug conjugatesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0869US8586716B2EPHB3-specific antibody and uses thereofHSU JEFF·Filed 2007·Granted Nov 19, 2013·3 cites·20 claims
- 0965US2018125996A1Antibody drug conjugatesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1060US11833215B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
- 1159US9006398B2EPHB3-specific antibody and uses thereofNOVARTIS AG·Filed 2013·Granted Apr 14, 2015·0 cites·8 claims
- 1259US2015320880A1Antibody drug conjugatesABRAMS TINYA·Filed 2015·Application pending·0 cites
- 1357US11357864B2Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 1450US2021228731A1Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Siew Ho Schleyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →